Status:
WITHDRAWN
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer
Lead Sponsor:
IsoRay Medical, Inc.
Conditions:
NSCLC
Non Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
For patients diagnosed with early (Stage I) non-small cell lung cancer, a lobe of lung is usually removed at surgery to treat the cancer. For some patients, the removal of a lobe of lung may leave too...
Eligibility Criteria
Inclusion
- Patients must have suspicious lung nodule for clinical stage I/recurrent non-small cell Lung Cancer
- Mass Tumor size \< 7 cm
- Patient must have a CT scan of the chest with upper abdomen within 90 days prior to date of pre-registration.
- Patient must have ECOG/Zubrod performance status 0,1, or 2.
Exclusion
- Patient has already received high dose radiation to the area
- Cancerous nodule is very close to the esophagus or spinal cord, thereby increasing the risk of radiation treatment
- Pregnancy or unwillingness to practice a form of birth control (i.e. abstinence, oral contraceptives, etc.)
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01237171
Start Date
November 1 2010
End Date
November 1 2010
Last Update
March 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College
New York, New York, United States, 10021